These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3079156)

  • 1. Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat.
    Lord RH; Hancock WW; Colby AJ; Padberg W; Diamantstein T; Kupiec-Weglinski JW; Tilney NL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):354-5. PubMed ID: 3079156
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergistic interactions between anti-interleukin-2 receptor (IL-2R) MAb and CyA in sensitized rat recipients of cardiac allografts.
    Kupiec-Weglinski JW; Sablinski T; Hancock WW; Mix CT; Tilney NL
    Transplant Proc; 1991 Feb; 23(1 Pt 1):285-6. PubMed ID: 1990533
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
    Hancock WW; Lord RH; Colby AJ; Diamantstein T; Rickles FR; Dijkstra C; Hogg N; Tilney NL
    J Immunol; 1987 Jan; 138(1):164-70. PubMed ID: 3097143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of recombinant interferon gamma and interleukin-2 and of a monoclonal antibody against interferon gamma on the rat immune response against heart allografts.
    Paineau J; Priestley C; Fabre J; Chevalier S; van der Meide P; Schellekens H; Jacques Y; Soulillou JP
    J Heart Lung Transplant; 1991; 10(3):424-30. PubMed ID: 1906747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment with cyclosporin A (CyA) and anti-interleukin 2 receptor monoclonal antibody (IL-2R MAb) abrogates the anti-idiotype response in rat recipients of cardiac allografts.
    Tanaka K; Kupiec-Weglinski JW; Hancock WW; Stunkel K; Diamantstein T; Tilney NL
    Transplant Proc; 1991 Feb; 23(1 Pt 1):281-2. PubMed ID: 1990532
    [No Abstract]   [Full Text] [Related]  

  • 6. Beneficial effects of monoclonal antibody targeting of CD4+ cells during the sensitisation but not effector phase of accelerated rejection of rat cardiac allografts.
    Hancock WW; Sablinski T; Milford EL; Tilney NL; Atkins RC; Kupiec-Weglinski JW
    Transplant Proc; 1990 Oct; 22(5):2115-6. PubMed ID: 2219313
    [No Abstract]   [Full Text] [Related]  

  • 7. Interleukin 2 receptor in rat allograft rejection.
    Bouchot O; Anegon I; Romaniuk A; Jacques Y; Soulillou JP
    Transplant Proc; 1990 Aug; 22(4):1995-7. PubMed ID: 2202134
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells.
    Tanaka K; Hancock WW; Osawa H; Stunkel KG; Alberghini TV; Diamantstein T; Tilney NL; Kupiec-Weglinski JW
    J Immunol; 1989 Nov; 143(9):2873-9. PubMed ID: 2530281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-interleukin 2 receptor monoclonal antibody therapy in rat recipients of cardiac allografts: the role of antibody isotype.
    Kupiec-Weglinski JW; Di Stefano R; Stunkel KG; Grutzmann R; Theisen P; Araneda D; Tilney NL; Diamantstein T
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):272-5. PubMed ID: 3126574
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo use of rapamycin suppresses neither IL-2 production nor IL-2 receptor expression in rat transplant model.
    Hamashima T; Yoshimura N; Ohsaka Y; Oka T; Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):723-4. PubMed ID: 8438457
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat.
    Komori A; Nagata M; Ochiai T; Nakajima K; Hori S; Asano T; Isono K; Tamatani T; Miyasaka M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):831-2. PubMed ID: 8094916
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppressive effects of leflunomide in a cardiac allograft model.
    Williams JW; Xiao F; Foster PF; Chong A; Sharma S; Bartlett R; Sankary HN
    Transplant Proc; 1993 Feb; 25(1 Pt 1):745-6. PubMed ID: 8438465
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective sparing of T suppressor cells by anti interleukin-2 receptor monoclonal antibodies (IL-2R mAbs) in vitro correlates with their therapeutic effects in vivo.
    Tanaka K; Turka LA; Ueda H; Diamantstein T; Milford EL; Carpenter CB; Tilney NL; Kupiec-Weglinski JW
    Transplant Proc; 1989 Feb; 21(1 Pt 1):475-6. PubMed ID: 2523145
    [No Abstract]   [Full Text] [Related]  

  • 14. Infiltration pattern of rat heart allografts during rejection.
    Westra AL; Romaniuk A; Ryffa T; Wildevuur CR; Nieuwenhuis P
    Transplant Proc; 1987 Feb; 19(1 Pt 1):374. PubMed ID: 3274787
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic strategies targeted at CD4+ cells obviate accelerated rejection of cardiac allografts in sensitized rats.
    Sablinski T; Sayegh MH; Kut JP; Hancock WW; Milford EL; Tilney NL; Kupiec-Weglinski JW
    Transplant Proc; 1991 Feb; 23(1 Pt 1):268-9. PubMed ID: 1990530
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts.
    Wei RQ; Schwartz CF; Lin H; Chen GH; Bolling SF
    J Surg Res; 1999 Feb; 81(2):123-8. PubMed ID: 9927530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged survival of rat cardiac allografts induced by intrathymic injection of donor bone marrow cells.
    Matsuura T; Hara Y; Imanishi M; Kanda H; Kurita T
    Transplant Proc; 1993 Dec; 25(6):3283-5. PubMed ID: 8266544
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-CD25 monoclonal antibody modulates cytokine expression and prolongs allografts survival in rats cardiac transplantation.
    Xia J; Jiang X; Huang Y; Zhang K; Xiao S; Yang C
    Chin Med J (Engl); 2003 Mar; 116(3):432-5. PubMed ID: 12781053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression.
    Hara Y; Matsuura T; Imanishi M; Tahara H; Kurita T
    Transplant Proc; 1994 Dec; 26(6):3226-8. PubMed ID: 7527955
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine and anti-interleukin 2 receptor monoclonal antibody therapy suppress accelerated rejection of rat cardiac allografts through different effector mechanisms.
    Hancock WW; DiStefano R; Braun P; Schweizer RT; Tilney NL; Kupiec-Weglinski JW
    Transplantation; 1990 Feb; 49(2):416-21. PubMed ID: 2106180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.